Drugs / 26489112
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01147887 | Jun → Aug 2010 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 26489112 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01147887 ↗ |
| Route | Oral | “Healthy volunteers will receive study drug (26489112) orally (by mouth) in the morning from Day 4 through Day 21.” NCT01147887 ↗ |